Joseph Carlson, MD
Orthopaedic Surgery · Bismarck, NDNPI 1013939693
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $713 of the $857 with a category attached, or 83.2%. It is spread thinly across 13 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $239, 2.7 times the $87 reported in 2019. That places this record below the midpoint for orthopaedic surgery clinicians in ND, where the typical reported total is $3,290.
Across 35 payments — averaging $24.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$134
- Smith+Nephew$129
- Heron Therapeutics, Inc.$109
- Zimmer Biomet$89
- Pfizer$82
- Vertex$81
- plus $235 from 7 others
What the payments were for
- Speaking & faculty fees$566%
- Food & beverage$71383%
- Education$8910%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 8 | $134 |
| Smith+Nephew | 5 | $129 |
| Heron Therapeutics, Inc. | 2 | $109 |
| Zimmer Biomet | 1 | $89 |
| Pfizer | 4 | $82 |
| Vertex | 4 | $81 |
| Kerecis Limited | 3 | $71 |
| Bioventus LLC | 1 | $41 |
| Pacira Therapeutics, Inc. | 2 | $34 |
| BD | 1 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Kyowa Kirin, Inc. | 1 | $15 |
| Omeros Corporation | 1 | $13 |
How this compares
$857 in reported general payments places this provider in the 25th percentile of 61 orthopaedic surgery providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 285 | $334 |
| Celecoxib | 12 | $164 |
| Clindamycin Hcl | 40 | $57 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Bismarck
- Brian DahlBismarck$31K
- Anthony KaschBismarck$5K
- Timothy BoppBismarck$4K
- Laura BruseBismarck$4K
- Duncan AckermanBismarck$3K
- Brock NorrieBismarck$3K
- Derrick CoteBismarck$3K
- Timothy JuelsonBismarck$3K
- Troy PierceBismarck$3K
- Ian FyfeBismarck$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.